(Q62062052)
Statements
a Single-center, One Arm, Open Clinical Study of BCMA Nanobody CAR-T Cell in Refractory/Relapsed Myeloma (English)
0 references
11 April 2018
0 references
10 April 2019
0 references
15
0 references
18 year
0 references
70 year
0 references